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A B S T R A C T
Purpose: In the current era of MRI-linac radiotherapy, dose optimization with arbitrary dose distributions is a
reality. For the first time, we present new and targeted experiments and modeling to aid in evaluating the
potential dose improvements offered with an electron beam mode during MRI-linac radiotherapy.
Methods: Small collimated (1 cm diameter and 1.5 × 1.5 cm2 square) electron beams (6, 12 and 20 MeV) from a
clinical linear accelerator (Varian Clinac 2100C) are incident perpendicular and parallel to the strong and lo-
calized magnetic fields (0–0.7 T) generated by a permanent magnet device. Gafchromic EBT3 film is placed
inside a slab phantom to measure two-dimensional dose distributions. A benchmarked and comprehensive
Monte Carlo model (Geant4) is established to directly compare with experiments.
Results: With perpendicular fields a 5% narrowing of the beam FWHM and a 10 mm reduction in the 15%
isodose penetration is seen for the 20 MeV beam. In the inline setup the penumbral width is reduced by up to
20%, and a local central dose enhancement of 100% is observed. Monte Carlo simulations are in agreement with
the measured dose distributions (2% or 2 mm).
Conclusion: A new range of experiments have been performed to offer insight into how an electron beam mode
could offer additional choices in MRI-linac radiotherapy. The work extends on historic studies to bring a suc-
cessful unified experimental and Monte Carlo modeling approach for studying small field electron beam dosi-
metry inside magnetic fields. The results suggest further work, particularly on the inline magnetic field scenario.
1. Introduction
The pursuit of clinical success in radiation therapy is a constant
trade-off between delivering sufficiently high dose levels to a target
region while sparing surrounding healthy tissue. The establishment of
image guided radiation therapy (IGRT) in the last two decades has
enabled more accurate and reproducible patient setup, which allows
treatment planning with smaller margins, yielding improved treatment
success [1–3]. As an alternative to the well-established imaging
methods with kV and MV photons, magnetic resonance imaging (MRI)
has gained broad interest in radiation therapy over the past years. MR
guided radiation therapy (MRgRT) has major advantages in soft tissue
contrast compared to kV and MV imaging, which, combined with high
time resolution, has the potential of non-invasive, non-ionizing, on-line
image guidance during treatment [4,5]. Additionally to patient setup
based on actual position and shape, motion tracking on arbitrary planes
during treatment becomes possible. This allows real-time guidance and
monitoring of anatomical changes for adaptive dose optimization [6,7].
Four main research programs have driven the development of in-
tegrated MRgRT systems over the past decade: The Australian MRI-
linac program [8], Edmonton’s rotating bi-planar system [9], Utrecht’s
system [10] (now commercialized as the Elekta Unity system) and the
ViewRay system [11]. While the ViewRay system was first released as
an integrated MRI-Cobalt machine, all four projects have focused their
developments towards integrated MRI and linear accelerator designs.
Although these integrated systems are currently intended for photon
radiation therapy, the technical prerequisites for treatment with elec-
tron beams are fundamentally provided by the linac design. Standard
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electron treatments in clinical routine are nowadays still performed
using standard or patient-specific cut-outs that are mounted into an
electron applicator. It has been shown that using the conventional
photon multileaf collimator (pMLC) for clinical electron beams at re-
duced source to surface distances (SSD) can replace treatment plans
using cumbersome and inefficient cut-out collimation with similar plan
quality for today’s standard electron treatments [12]. Alongside ad-
vantages in efficiency and quality assurance, using the pMLC for elec-
tron beam collimation also allows for advanced treatment techniques
like modulated electron radiotherapy (MERT) [13–16], or the combi-
nation of photon and electron beams in mixed beam radiotherapy
(MBRT) [17–19].
Historically, researchers have also investigated the use of magnetic
fields to improve the dosimetry characteristics of electron beams
through gross Lorentz force deflections. These studies can be broadly
summarized into two areas with slightly different goals: (1) local dose
enhancement through local transverse magnetic fields, and (2) lateral
dose spread reduction via inline local or globally encompassing mag-
netic fields.
For local transverse fields there has been a wide variety of both
experiments and simulation based studies. By adding a strong and local
transverse magnetic field near the end range of a clinical electron beam
there is the chance to encourage the electrons to stop in a reduced
distance from the surface, thereby giving rise to a local dose enhance-
ment effect. Of the many studies, hypothetical magnetic fields were
modeled [20–22], real dipole magnets were used [23–26], or modeling
of realistic magnet systems employed [27]. This direction of research
has all but ceased to exist in the current era. Put simply, it appears
impractical to generate the types of local transverse magnetic fields that
would significantly improve current electron beam therapy techniques.
For inline or longitudinal fields, there is only a small collection of
studies concerned with modern practical therapeutic electron beams. In
1985 Weinhous simulated several coil magnet devices surrounding a
water phantom and with 20 MeV and 30 MeV electron beams of 10 cm
diameter incident [28]. The coil devices had strong fringe gradients that
altered the electron beam properties before they reached the phantom,
and peaked at around 3 T inside the phantom. The fields were radically
different from pure global inline fields. Hence strong changes to the
electrons occurred before the phantom, and the dose changes modeled
in the phantom were more of an effect of this process. In 1993 Bielajew
simulated 20 MeV pencil beams in 3 and 20 T uniform global fields
[29]. Broad beam doses were emulated by using the dose from a single
pencil beams and applying the Geometry-Equivalence Theorem [30]
throughout a broad phantom. There was a prediction of a distinct pe-
numbral narrowing for the emulated broad beam. In 2001 Litzenberg
performed experiments with a 3.5 T superconducting solenoid magnet
and 10 cm circular electron beams of 10, 20, 30, 40, and 50 MeV [31].
The fringe field of the magnet caused significant upstream focusing of
the electron beams and so it was not possible to distinguish the impact
of the local field in the phantom versus the effects from upstream fo-
cusing. Finally in 2005 Chen performed a simulation study of the 2001
Litzenberg work in order to gain insight into the various unexplained
results of the experiments. The simulation results confirmed the theory
regarding the dose enhancement being associated with external beam
focusing. In summary, there is no clear experimental work to confirm
the 1993 predictions by Bielajew, nor studies of field strength and ar-
rangements similar to modern day MRI-linac system prototypes. For
example around 0.5 to 1.5 T in strength and of reasonably high uni-
formity surrounding the phantom.
The purpose of this work is to establish a comprehensive experi-
mental and corresponding in-silico setup to robustly determine dose
distributions of small clinical electron beams in the presence of various
magnetic field arrangements. The work is targeted to bring new in-
formation that is highly relevant for the modern day themed research
directions such as optimized dose planning and modulated electron
beams, all in the overarching theme of real-time MRI-guidance with a
potential electron beam mode.
The novelty is specifically to:
i) Investigate experimentally the changes to small clinical electron
beams in magnetic fields with strengths and directions associated
with current MRI-linac systems, such that the dosimetry features can
be attributed purely to the local magnetic field effects, rather than
from beam transport artifacts as seen in previous studies. This is
achieved via the use of specially designed magnetic field apparatus
that creates a unique local magnetic field that surrounds the dosi-
metry phantom.
ii) Present a benchmarked and robust magnetic field capable Monte
Carlo framework that includes a commissioned electron beam model
coupled with finite element magnetic field data of the real experi-
mental device.
2. Methods
2.1. Transverse and inline magnetic field setup
A permanent magnet device called Magnetic Apparatus for
RaDiation Oncology Studies (MARDOS) as introduced by Oborn et al.
[32] is used to generate a magnetic field up to 0.713 T over a volume of
several litres, large enough to encompass a small phantom. The two
banks of NdFeB permanent magnets are held in a steel yoke and fo-
cusing cones can be inserted to concentrate the magnetic flux across the
pole gap. Moving the magnet banks towards and apart from each other
as well as inserting the cones changes the magnetic field distribution
and maximum field strength of the setup.
The MARDOS system was designed by optimizing COMSOL
Multiphysics finite element models of two banks of NdFeB permanent
magnets incorporated in a steel frame or yoke. Once constructed, the
magnetic performance of the system was mapped out and the data used
to fine tune the magnet and steel grade values in the model, such that it
matches the experimental performance. The fields were measured with
a MAGSYS Gaussmeter HGM09s which has a calibration accuracy of
± 0.5% over the range of 0–1 T. The end result was that there is a 2%
match to the magnetic field values between the banks over all combi-
nations of bank settings. During any experimental work, the banks are
adjusted to predetermined positions and the magnetic field strength
between the cones spot checked with a portable field probe to ensure
the setup matches the benchmarked modeling scenarios.
MARDOS can be rotated in order to align the primary electron beam
direction perpendicular (referred to as transverse setup) or parallel
(referred to as the inline setup) to the main magnetic field direction.
Solid water slabs with a size of 30 × 30 cm2 and thickness of 0.1 to
5 cm are stacked in the MARDOS system and irradiated parallel to the
slab interfaces (transverse setup) and perpendicular to the slab inter-
faces (inline setup). Figs. 1 and 2 show the different applied setups of
the MARDOS system. For all measurements, the MARDOS system is
positioned such that a source to magnet isocenter distance (SID) of
150 cm is achieved. Electron beams (6, 12 and 20 MeV) are produced
using a Varian Clinac 2100C linear accelerator and 2000 monitor units
are applied for each measurement. Gantry position is at 270 degrees for
all MARDOS measurements and the electron beam is collimated with
the photon MLC to a 10 × 10 cm2 field size defined at machine iso-
center (at 100 cm). Final collimation of the electron beam before en-
tering the magnetic field of the MARDOS system is achieved by dif-
ferent physical components for the different setups. Without the
focusing cones in place, final collimation is performed with a drilled
cerrobend mold, yielding a circular collimation of 1 cm in diameter. For
the setup with focusing cones in place, final collimation is achieved
with a square window of 1.5 × 1.5 cm2 at the cone tips.
The fringe fields were also modeled and measured outside of the
steel yoke and found to be less than 0.001 T. This has negligible impact
on electron beam transport, for example the radius of curvature for a
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6 MeV electron traveling in a 0.001 T magnetic field is 21.6 m.
2.2. Zero magnetic field reference setup
To establish reference conditions with no magnetic field, all mea-
surements performed within the magnet are repeated without the
MARDOS magnet. These 0 T reference experiments are performed by
mounting the collimation hardware and phantom inside a dedicated
magnetic field free aluminum replica of the MARDOS frame. To re-
produce the setup with focusing cones, the cones are removed from the
MARDOS device and mounted in the replica frame.
2.3. Film measurements
Gafchromic EBT3 film (Ashland, Convington, USA) placed in the
solid water slab phantom is used for dose measurements in transverse,
inline and zero magnetic field. The film is calibrated for a dose range of
0–10 Gy following the protocol outlined by Devic et al. [33] using a
standard single-channel analysis procedure (red channel) to convert net
optical density to dose. The film are scanned on an Epson Expression
10000XL flatbed scanner with 72 dpi resolution. Pieces of film with
dimensions of 10 × 25 cm2 and 5 × 5 cm2 are irradiated in the
transverse and inline setup, respectively, in the MARDOS magnet as
well as in the zero magnetic field reference setup. Fig. 3 shows an il-
lustration of the film placement in the transverse setup with indication
of the incident electron beam and expected beam deflection due to
Lorentz force.
For the inline setup with and without cones, the 5 × 5 cm2 pieces of
film are positioned such that the impinging electron beam is aligned
with the center of the film. Table 1 shows an overview of the acquired
film measurements in the different setups.
No measurements are performed in the transverse setup with a
maximum magnetic flux density of 0.713 T, as the electron beam would
not reach the phantom due to the deflection caused by the Lorentz
force.
2.4. Monte Carlo framework
For characterization of the electron beams, a multiple source MC
beam model as described by Henzen et al. [16] is commissioned and
validated for the Varian Clinac 2100C for the three applied electron
energies (6, 12 and 20 MeV). The beam model consists of a foil and a
jaw source, both divided into an electron and a photon part. For the
beam model commissioning of a specific treatment unit, depth dose and
air profile measurements at an SSD of 70 cm are collected and
Fig. 1. Placement of the solid water slabs within the MARDOS system for the transverse (left) and inline without cones (right) setup. Gafchromic EBT3 film pieces are
placed parallel (left) and perpendicular (right) to the primary beam direction at different off-axis distances and depths, respectively.
Fig. 2. Placement of the solid water slabs within the MARDOS system for the
inline setup with cones. Gafchromic EBT3 film pieces are placed perpendicular
to the primary beam direction at different depths.
Fig. 3. Gafchromic EBT3 film as irradiated in the transverse magnetic field
setup. Pieces of film are placed on the central axis plane as well as 5 mm and
10 mm off-axis for all measurements in the transverse setup.
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combined with pre-calculated MC configuration data. The beam model
is connected to the Swiss Monte Carlo plan (SMCP) [34], where particle
transport through the pMLC is performed with the PIN MC algorithm
[35] and phase space files are collected for further particle transport
and dose calculation. Magnetic flux maps for the different setups of the
magnet system are calculated using finite element calculation using the
COMSOL Multiphysics® software (COMSOL AB, Stockholm, Sweden)
and are exported as three dimensional lookup tables. The geometric
setup of the MARDOS system is modeled and particle transport is si-
mulated using the Geant4 simulation toolkit [36] version 10.2 with
standard electromagnetic physics models. The recorded phase space
files from the beam model as well as the lookup tables for the magnetic
field are loaded in the Geant4 simulation to perform accurate particle
transport with and without the magnetic field. Dose is scored at 1 ×
1 × 1 mm3 resolution throughout the phantom volume. An energy-
specific normalization factor is determined to calculate absolute dose in
units of Gray. The calculated dose distributions are compared to the
measurements by means of dose profiles and two-dimensional gamma
evaluation [37].
To further assess the impact of an inline magnetic field on an clin-
ical electron beam, an additional MC study is performed. Electron
beams of the three commissioned energies 6, 12 and 20 MeV are col-
limated with the pMLC to a circular field with a 10 × 10 cm2
equivalent field size. A water phantom with unilateral lung and bone
inhomogeneities is placed at an SSD of 100 cm and a homogeneous
inline magnetic field of 0.713 T is activated from 10 cm upstream of the
phantom. The resulting dose distributions are compared to the re-
ference situation without magnetic field in terms of dose enhancement
and change of penumbral fall-off.
3. Results
3.1. Magnetic field distribution
The MARDOS system produces a strong magnetic field encom-
passing a substantial volume, as displayed in Fig. 4. However im-
portantly for this study, the field distribution has some unique features.
In the top figure a homogeneous magnetic flux density with a maximum
of 0.265 T and 0.353 T is reached with an open gap of 15 cm and 10 cm,
respectively. The iron yoke of the MARDOS system strongly contains
the magnetic flux, allowing for electron beams to travel very close to
the phantom before entering these strong fields. For the transverse
experiments, the electron beam undergoes almost no deflection before
striking the phantom. This is evident from the results of the next sec-
tion, and importantly allows us to examine the local effects of the
magnetic field essentially within the phantom volume.
With the steel cones in place (bottom figure), a maximal magnetic
flux density of 0.713 T is obtained over the gap of 5 cm between the
cone tips. In this arrangement for inline experiments, it can be seen that
the electron beam experiences almost no magnetic field during its path
to the phantom volume. This is key requirement to ensure the effects on
the electron beam are induced by inline magnetic field within the
phantom rather than any upstream focusing effects.
3.2. Transverse field results
Fig. 5 shows measured dose distributions on the central axis plane,
the 5 mm off-axis plane and the 10 mm off-axis plane for three electron
energies in the transverse magnetic field setup for the three electron
beam energies. The film data shows a substantial deflection of the
electron beam for the three initial energies (6, 12 and 20 MeV) for the
two non-zero field strengths ( =B 0.265max T and 0.353 T, respectively)
when compared to the reference measurements without a magnetic
field. Also apparent in the 6 MeV, 0 T image is an outline of the
background photon contamination, or scattered photons produced in
the head of the linac. This takes the shape of the final 1 cm diameter
cerrobend collimator outline and it contributes less than 1% of the
primary electron beam dose. It is not evident when the magnetic field is
introduced simply due to colormap thresholding changing to account
for a small relative dose increase when the magnetic fields are applied.
Fig. 6 shows the corresponding isodose curves on the central axis plane.
The beam deflection can be observed in all isodose lines and a lateral
shift of up to 7 mm is measured for the lowest indicated isodose line,
that is 0.5, 1.0 and 1.5 Gy for the 6, 12 and 20 MeV beam, respectively.
This is confirmed by a lateral dose profile in a depth of 1.5 cm, as shown
in the bottom right of Fig. 6, where the respective maximum dose value
of the profile is shifted by up to 5 mm. For all three electron energies, a
drop in the dose is apparent in the isodose lines after initial build-up at
a phantom depth of around 0.5 cm. The cause of these artefacts are
small air gaps between the slabs of the solid water phantom and the
irradiated film, which perturb electron scattering conditions if the film
measurement plane is parallel to the incident beam direction [38].
The most important clinical result of the perpendicular work would
be considered the changes to the 20 MeV. As indicated in Fig. 6, there is
a clinically significant reduction of 10 mm in penetration depth of this
beam, as well as a mild reduction of the full width at half maximum
(FWHM) at 1.5 cm depth.
Monte Carlo results are in good agreement with the acquired film
measurement, as exemplarily indicated in Fig. 7 for the 12 MeV beam in
a 0.353 T magnetic field. The acquired dose distributions on the central
axis plane are shown for the film data (left) and the MC simulation
(center) and a gamma map is shown on the right. A global dose dif-
ference criterion of 2% of the maximum measured reference dose, a
distance-to-agreement criterion of 2 mm and a dose threshold of 20% is
applied. Table 2 shows the results of the gamma evaluation on the
central axis plane for the measured and simulated dose distributions in
the transverse setup.
3.3. Inline field results: 12 MeV
In the inline setup, for a magnetic field with =B 0.353max T as well
as 0.713 T, a dose enhancement of the dose profiles can be observed
compared to the corresponding =B 0 T measurement. Two-dimen-
sional dose distributions of the measured films are shown in Fig. 8 for a
12 MeV electron beam in a 0.713 T inline magnetic field. For all in-
vestigated depths, an increase of the dose can be observed in the pre-
sence of a magnetic field compared to the reference condition. This
observation is quantitatively shown in the corresponding lateral dose
profiles in Fig. 9. An increase of the dose level is prominent for all
Table 1
Overview of the acquired film measurement data in the magnetic field setup.
Energies Collimation Magnet setup Bmax Film measurements
6, 12, 20 MeV 1 cm circular transverse 0.265 T Central axis plane, 5 and 10 mm off-axis
6, 12, 20 MeV 1 cm circular transverse 0.353 T Central axis plane, 5 and 10 mm off-axis
12 MeV 1 cm circular inline 0.353 T Perpendicular @ 1, 2, 3, 4, 5 cm depth
20 MeV 1 cm circular inline 0.353 T Perpendicular @ 1, 3, 5, 7, 9 cm depth
6 MeV 1.5 cm square inline with cones 0.713 T Perpendicular @ 1, 2 cm depth
12 MeV 1.5 cm square inline with cones 0.713 T Perpendicular @ 1, 2, 3, 4 cm depth
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measured depths, with a relative dose difference of up to 25% in 4 cm
depth.
3.4. Inline field results: 6 MeV
The same effect is present for the 6 MeV beam in the inline setup
with cones, where the maximal magnetic field strength is 0.713 T. For
the measurements in both 1 cm and 2 cm depth, a substantial increase
of the dose values can be observed, as indicated by the lateral dose
profiles shown in Fig. 10. An increase of measured dose of 100% is
observed with respect to the reference measurement without a mag-
netic field. This results in a narrowed field size when re-normalizing to
a given dose level at the center of the field, for example a decreased
FWHM of −1.5 mm in 2 cm depth compared to 0 T. Additionally, the
penumbral fall-off from the 80% to 20% dose level is reduced by
−2 mm (−20%). As shown in Figs. 9 and 10, MC results are within 2%
dose differences or 2 mm distance-to-agreement.
3.5. Inhomogeneity simulation study results
Fig. 11 shows the results of the additional MC study of a clinically
relevant field size on a phantom including inhomogeneities.
The dose distributions are normalized to the respective dose max-
imum of the =B 0 T situation for each energy. A dose increase from and
reduction of the penumbral fall-off can be observed for all energies,
being most prominent for the 6 MeV electron beam (50% dose increase
Fig. 4. Top: Top view of the magnetic flux density (color) and direction (red arrows) of the MARDOS system in the setup, where a maximum field strength of 0.265 T
is achieved in the phantom volume. Bottom: Similar view for the inline measurements where the 0.713 T field is produced over a 5 cm cubic volume between the
cone tips. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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and −32% reduction of penumbral fall-off from 80% to 20% in 2 cm
depth) and less pronounced for the higher energies. The results of this
in-silico investigation support the potential dosimetric offerings of
electron beams in an inline MRI-linac system.
4. Discussion
4.1. Novelty of work
Despite the wide range of historic research and experiments con-
ducted on radiotherapy electron beams and changes induced by mag-
netic fields, some simplified scenarios have been overlooked or not
Fig. 5. Dose distributions of the film measurements on the central axis plane (CAX, front), 5 mm off-axis (middle) and 10 mm off-axis (back) planes in the transverse
magnetic field setup. Measured dose is shown for the three different electron beam energies and two non-zero magnetic field strengths. Magnetic field direction is
marked in the lower left subplot, axis units are in centimeters.
Fig. 6. Isodose curves and lateral dose profiles of the central axis plane (CAX) measurements in the transverse setup for the three different electron beam energies and
two non-zero magnetic field strengths. The 20 MeV beam shows a 10 mm reduction in the penetration depth of the 15% isodose line as we as a 5% reduction in
FWHM at 1.5 cm depth.
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verified. For the first time, our experiments of linac-generated electron
beams show the minor reductions in electron beam widths caused by
inline magnetic fields of 0.713 T. The effect is caused by the local
magnetic field rather than by changes to electron paths above the
phantom as was the case in the previous studies [39,31].
In particular, our unique experimental apparatus with a very low
fringe field has given us the ability to remove any effects of electron
beam transport above the phantom.
Our work also brings together a comprehensive in-silico framework
using a designated MC electron beam model, finite element calculations
to characterize the magnetic field map, and a general purpose MC code
to simulate electron beam transport and energy deposition. Importantly
the modeling predictions shows results within clinical agreement of the
measurements correspondingly performed.
4.2. Film artefacts
While the transverse setup shows the expected deflection of the
clinical electron beam, artefacts in the dose distributions are observed
in the superficial region, which is associated with small air gaps. This
effect was already described by Dutreix et al. [38], when a film is
placed parallel to the primary beam. A designated phantom could be
used to minimize such artefacts [40] or a tilting angle of the phantom
could be introduced to avoid the primary beam to be exactly parallel to
the film plane [41]. Due to the mechanical properties and placement of
final collimation in the present experimental setup, such a tilting is not
feasible for the measurements in the transverse orientation. However,
the observed artefacts do not substantially influence the results pre-
sented in this work as confirmed by the MC simulation data.
4.3. Dose enhancement effects of transverse fields
Previous work has suggested the use of such strong transverse
magnetic fields to ameliorate electron dose distributions [23–26]. To
achieve this effect in the context of MRI-linac radiotherapy, the electron
beams would have to be shielded from the magnetic field up to the
surface to prevent them from spiraling away before reaching the pa-
tient. Our results for the transverse magnetic field work has shown
indeed how small electron beam dosimetry can be slightly improved
through a reduction in low dose penetration and minor width reduc-
tions, at the cost of asymmetric beam shape. The MARDOS device al-
lows for an electron beam to travel essentially unperturbed by a mag-
netic field above the phantom region. Hence we were able to observe
the raw effects of a very local transverse magnetic field. In the most
realistic sense, it would seem this magnetic field property would not be
permittable inside an MRI-linac system. By nature, a patient inside an
MRI is required to be surrounded by a highly uniform magnetic field. In
this case even a 20 MeV electron could be completely deflected by the
MRI field and so not reach the patient. The data presented in this sec-
tion of work therefore has the most impact for testing the predictions of
our multifaceted modeling workflow rather than describing a feasible
dose enhancement method using transverse magnetic fields. Our results
Fig. 7. Measured dose distribution (left) and MC simulation (middle) on the central axis plane for a 12 MeV beam in a 0.353 T magnetic field. The resulting gamma
map is shown (right) with a global 2% and 2 mm criterion and a dose threshold of 20%.
Table 2
Results of 2D gamma evaluation for the transverse setup. A global 2% and 2 mm
criterion and a dose threshold of 20% is applied.
Energy Bmax # points Mean Passing rate
6 MeV 0 T 411 0.353 93.4%
6 MeV 0.265 T 386 0.451 97.2%
6 MeV 0.353 T 367 0.180 100.0%
12 MeV 0 T 594 0.242 96.0%
12 MeV 0.265 T 550 0.166 99.3%
12 MeV 0.353 T 585 0.212 99.5%
20 MeV 0 T 885 0.255 96.4%
20 MeV 0.265 T 922 0.225 99.7%
20 MeV 0.353 T 914 0.327 96.9%
Fig. 8. Dose distributions of the film data placed at depths (d) in the phantom in an inline magnetic field setup for the 12 MeV electron beam.
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indeed show a good quality match over the various electron beam en-
ergies and magnetic field strengths.
4.4. Dose enhancement effects of inline fields
On the other hand, the presented results show the enhancement of
dose in the inline setup, where the main magnetic field is parallel to the
incident electron beam, compared to a reference situation without an
external magnetic field. The magnitude of the dose enhancement can be
associated in part with the small measured field size, which emphasizes
this effect, but the same qualitative characteristics are observed for a
clinically more relevant field size. In this inline setup, electrons are not
affected by the magnetic field as long as their direction of motion is
aligned with the magnetic field lines. As soon as a perpendicular
component arises due to beam divergence or scattering, the electron is
forced on a helical path around the axis of the magnetic field direction
as determined by the Lorentz force. The inline field therefore en-
courages laterally scattering electrons in the phantom to propagate
parallel to the field direction. This results in a narrowed field size of the
electron beam and a steeper lateral penumbra in the resulting dose
distribution.
It is important to note here that these effects would also be observed
with electrons transporting above the phantom surface, if they were
subject to the same strong inline fields. In our experimental setup, as
described in Section 2.1, there is no impact from the very low fringe
field of the magnet system.
While electrons are considered dosimetrically beneficial compared
to photons due to their finite range, the wide penumbra of electron
beams is a limiting property to spare normal tissue close to a target
volume. Earlier studies have reported the reduction of electron dose
penumbra on a simulation level with conceptual magnet designs and
simplistic, mono-energetic electron beams [28,29]. This work
Fig. 9. Lateral dose profiles of the film data placed at depths (d) in the solid water phantom in an inline magnetic field setup for the 12 MeV electron beam. Lines
indicate the measured profiles without (solid) and with 0.713 T magnetic field (dashed), markers show the corresponding simulation data. A general dose increase or
enhancement in the order of 25% is observed at each depth.
Fig. 10. Lateral dose profiles of the film data placed at depths (d) in the phantom in an inline magnetic field setup for the 6 MeV electron beam. Lines indicate the
measured profiles without (solid) and with 0.713 T magnetic field (dashed), markers show the corresponding simulation data. A strong dose increase or enhancement
of 100% is observed at both depths.
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experimentally confirms the presumption of ameliorated dose dis-
tributions of therapeutic electron beams in the presence of local inline
magnetic field similar to a MRI-linac system. Consequently, these re-
sults could be a driver towards the development of a next generation of
an inline MRI-linac with an electron mode included.
4.5. Possibility of electron beam mode in MRI-linacs
The currently commercially available MRI-linacs are designed with
the main magnetic field perpendicular to the incident photon beam
[10,11], which renders the possibility of an electron mode improbable.
The two other far advanced projects in contrast are operating with an
inline design [8,9], which makes them predestined candidates for fur-
ther research on this topic. It should still be noted that the present work
does not cover the practicalities of producing an electron beam in a
MRI-linac system. Technical challenges to generate and propagate a
therapeutic electron beam in a linear accelerator remain to be solved, as
the magnetic fringe field is likely to influence the treatment head. The
properties of a clinical electron beam is therefore expected to be
changed with a magnetic fringe field present in the accelerator head.
Proper characterization of the electron beam is hence key to enable a
MC based planning framework for such a concept, which remains to be
addressed in future work. Nonetheless, the established framework and
presented results provide a data basis for further investigation towards
MRI-guided electron therapy.
5. Conclusion
For the first time, experiments of therapeutic energy linac-generated
electron beams in both transverse and inline magnetic field directions
have been performed within a common experimental and simulation
framework. The results bring additional useful information on how
small electron beams behave in magnetic field orientations and
strengths similar to modern day MRI-linac systems. As the Monte Carlo
simulations are in agreement with the measurements, we are
encouraged to conduct further modeling based investigations into po-
tential future MRI-linacs with an electron beam mode. The most pro-
mising arrangement would be an inline MRI-linac system with a photon
MLC to enable dose optimization of small electron beams that in-
herently display a superior dose distribution over those without mag-
netic fields. It would then be natural process to investigate the potential
benefits of mixed beam real-time MRI-guided radiotherapy.
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